An NIH Director's Wednesday Afternoon Lecture Series Event
From the Rivers of Babylon to the Coronary Blood Stream
Speaker: Barry S. Coller, M.D.
David Rockefeller Professor of Medicine
Head, Laboratory of Blood and Vascular Biology
Physician-in-Chief, The Rockefeller University Hospital
Vice President for Medical Affairs
Wednesday, November 7, 2007
3:00-4:00 p.m.
Masur Auditorium
Clinical Center
National Institutes of Health
Videocast of lecture
For information and accommodations, call Gloria Hairston at (301) 594-6747.
Sign language interpreters will be provided. Individuals with disabilities who need accommodations to participate in the lecture should call (301) 594-5595 five days ahead or contact the Federal Relay Service (TTY) at 1 (800) 877-8339.
Accreditation: The NIH/Foundation for Advanced Education in the Sciences (FAES) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The NIH/FAES designates this educational activity for 1 credit per session up to a maximum of 45 category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits actually spent in the educational activity.
The CME educational objective for this activity is to enable participants to: 1) Identify key questions in the speaker's area of investigation, and 2) Identify approaches used by the speaker to answer these questions.
Past Astute Clinician Lectures
"Listening to Patients: Lessons Learned in the Development of Cancer Immunotherapy"
Wednesday, November 1, 2006 - Dr. Steven A. Rosenberg, M.D.
"Inflammation, CRP and Cardiovascular Risk: Is It Time to Change the
Framingham Risk Score?"
Wednesday, November 2, 2005 - Dr. Paul M. Ridker, M.D.
"Insulin
Resistance and Metabolic Syndromes: Different Names, Different
Concepts, Different Goals"
Wednesday, November 3, 2004 - Dr. Gerald M. Reaven, M.D.
"Cochlear
Implants, Past, Present, and Future,"
Wednesday, November 5, 2003 - Richard T. Myamoto, M.D.
"AIDS:
A Window on Infectious Diseases,"
Wednesday, November 06, 2002 - Henry Masur, M.D.,
Chief, Critical Care Medicine Department, NIH
"STI571:
A Tyrosine Kinase Inhibitor for the Treatment of Chronic Myelogenous
Leukemia (CML) Validating the Promise of Molecularly Targeted
Therapy,"
Wednesday, November 07, 2001 - Brian Druker, M.D.
"The
Patients Who Taught Me and Led to My Discoveries in Congenital
Adrenal Hyperplasia,"
Dec. 13, 2000 - Maria I. New, M.D.